✦ LIBER ✦

Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia

✍ Scribed by H. M. Kantarjian, S. Padmanabhan, W. Stock, M. S. Tallman, G. A. Curt, J. Li, A. Osmukhina, K. Wu, D. Huszar, G. Borthukar, S. Faderl, G. Garcia-Manero, T. Kadia, K. Sankhala, O. Odenike, et al

Book ID: 113064513
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 188 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9660-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Study to Assess the Safety, Tole

Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid Tumors

✍ Taito Esaki; Takashi Seto; Hiroshi Ariyama; Shuji Arita; Chinatsu Fujimoto; Koic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

A Phase I study to assess the safety, to

A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors

✍ J. R. Infante; R. Kurzrock; J. Spratlin; H. A. Burris; S. G. Eckhardt; J. Li; K. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 338 KB

A Phase I study to assess the safety, ph

A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia

✍ Kosuke Tsuboi; Toshiya Yokozawa; Toru Sakura; Takashi Watanabe; Shin Fujisawa; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

A multicenter open-label phase I/II stud

A multicenter open-label phase I/II study to assess the safety, tolerability, and efficacy of three dose levels of TuNEX in patients with rheumatoid arthritis

✍ Der-Yuan Chen; Ning-Sheng Lai; Ling-Ying Lu; Hsiu-Cheng Chou; Yi-Hsing Chen; Tsu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 Chinese ⚖ 428 KB

509 The OPAL Study: A Phase II Study to

509 The OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia

✍ Jorge Cortes; Eric Feldman; Karen Yee; Martin Toal; Alison Richardson; Anthony C 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 130 KB

A placebo-controlled, double-blind, dose

A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shock

✍ Peter E Morris; Brian Zeno; Andrew C Bernard; Xiangning Huang; Shampa Das; Timi 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 300 KB